- Email: [email protected]
809. Adenoviral Delivery of Pro-Caspase3 to Ovarian Carcinoma Cells Induces Apoptosis and Enhances Sensitivity to Dominant-Negative Mutant Survivin
!" E
) -#(# "
" @'D/
2",
" @'D -' @'D/ 23 .> ?
-' .> ?23/ ' @'D
3 @'D"
58H $&6# 6B;H 4,&8# ' @'D -899 #)/
# ( ( 3 3 23 ' .> ?23 4,&8# T4=;=# T4:;# T(A# 8T$&6# 23 3 @'D
"5 ": "=
' @'D ' .> ?23
# $&6# 58H ' @'D -899 #)/ :;5H ' .> ?23-899#)/ &8&H
# ( (
3 23 ' .> ?23 ' @'D @'D" / % 8 B DEEE'71,1F#
807. Induction of Apoptosis and Cell Cycle Stopped ransfer in Transfer with Adenovirus Mediated SART1 Gene T Human Lung and Breast T umor Cell Line Tumor Mami Hosokawa,1 Shigemitsu Takashima,1 Shigeaki Shichijo,2 Kyogo Itho,2 Hiro Wakasugi,3 Yoichi Takaue,3 Igor Dmitriev,4 David Curiel,4 Yuji Heike.5 1 Medical Oncology and Clinical Reserch, National Shikoku Cancer Center, Matsuyama, Ehime, Japan; 2Immunology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; 3 Pharmacology, National Cancer Center Reserch Institute, Tsukiji, Tokyo, Japan; 4Gene Therapy Program, University of Alabama at Birmingham, Alabama, Birmingham, United States. ('@ 8 1 3
G
CD'"',B
D C 3
('@ 8
('@ 8
%
3
('@ 8
" " -@ $/ C#)M89 3
'&65 #?;
,6 6:
:9H ;, 0 *"C6B9 N@;&"8
B9H ;,
N@;&"8 *"C6B9 $#(886
,%# ,6 ;, '&65 #?;
,%# ,6 ,%#
6: D '&65 #?;
- 8% , $,&2/ ,%# ('@ 8
' 8% , $,&2
,%#
S264
808. Enhancement of Thymidine Kinase-Mediated Killing of Malignant Glioma by BimS, a BH3-Only Cell Death Activator Takashi Yamaguchi,1 Takashi Okada,2 Mutsumi Nagai,1 Koichi Takeuchi,3 Souji Shinoda,1 Toshio Masuzawa,1 Keiya Ozawa,2 Toshiya Inaba.4 1 Department of Surgical Neurology, Jichi Medical School, Minami-kawachi, Tochigi, Japan; 2Division of Genetic Therapeutics, Jichi Medical School, Minami-kawachi, Tochigi, Japan; 3Department of Anatomy, Minami-kawachi, Tochigi, Japan; 4 Department of Molecular Oncology, Hiroshima University, Hiroshima, Hiroshima, Japan. C 3 -C(." / % - ./
C(." % . " @ 2", 2 2", "
3
C(." % . 0
3 % 2 2C=" 2",
$*' '
2>D 2D 2( 2(
D: 2>D 2D ( 2
C(." % .
C(." % . "
3 DN-'.," DN/ 2( -'.,"2(/ 2D -'.,"2D/ C(." -'.," / 0
,5= '.," 2( '.,"2D
" '.," ,5=
,6 2 ,5=2 3
2"3D '.,"2( '.,"2D
' 4,&8 '8;, "6=9 4=;= ,6
'.,"2( " " '.,"2( '.,"
4,&8 . '.,"2D '
'.,"2( '.," % .
69 2 '.,"2( '.," % .
' 3 2 23 - 2",
C(." % . / $
809. Adenoviral Delivery of Pro-Caspase3 to Ovarian Carcinoma Cells Induces Apoptosis and Enhances Sensitivity to Dominant-Negative Mutant Survivin Tristan R. McKay, Steven J. Bell, Tencho Tenev, Nicholas R. Lemoine, Iain A. McNeish. 1 ICRF Molecular Oncology Unit, Imperial College School of Medicine, London W12 0NN, United Kingdom. ( 3 0 " " 3 = 0
G
3 " =6' " = 0
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
!" " 5"
? " =6'
3 0 " =
810. Effects of HSV Amplicon V ectors Mediate TIMP-3 Vectors Gene T ransfer in Human Glioma Cell Lines Transfer Paula Y. P. Lam,1 ChuJun Yuan,1 Kam Man Hui.1 1 Cellular and Molecular Research, National Cancer Centre, Singapore.
891,= 1
! >*
# ! >*
0 ! >* " ! >*
! 'A
! >* 3 ' "! >*
>"
3
G
! >* ' "! >* " "
)
(
3 3 ->#/
># 1
3
G - 3 ##! / -
#!(/ #!"= ) 3 #!"=
I I I #E
C
3 C(."8
#!"= 3 3 ?
#!"=
#!"=
C #!"= $*'
@*'
C F -+ ( ,998 # =7 &58"B98/ $*' 1
1
88 3 89B % #!"= 8,389; % C F
3
&:H #) 89 0
#!"= 3
#!"= 3
$
"=B 4:;# 4,&8 (?;B; 85HI ,&HI &H
;, #)9& 3 "=B #) 9& &9
69H '
3
#)
812. Exploiting Molecular Pathways for Breast Cancer Treatment: Ad-mda7 Enhances Activity of Conventional Cancer Agents
81 1. 811.
!
C A" A" 0
A" @*'" 3
)
" -?*/
3
"
?*
?*" G ,V &V" -,"&'(/
Ad-PTEN: A Novel Anti-Melanoma Agent In V itro Vitro
Helena Yang,1 Abner Mhashilkar,1 Alexis Stewart,1 Su Ekmekcioglu,2 Yuji Saito,4 Kerry Seiger,1 Robert Schrock,1 Eric Onishi,1 Xin Swanson,1 Lou Zumstein,1 David Snary,3 Jack Roth,4 Rajagopal Ramesh,4 Elizabeth Grimm,2 Sunil Chada.1 1 Introgen Therapeutics Inc., Houston, TX, United States; 2 Bioimmunotherapy, UT, MD Anderson Cancer Center, Houston, TX, United States; 3Imperial Cancer Research Fund, London, United Kingdom; 4Thoracic and Cardiovascular Surgery, UT, MD Anderson Cancer Center, Houston, TX, United States. # G ! >* Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
Abner Mhashilkar,1 Kerry Seiger,1 Alexis Stewart,1 Kelly Hunt,2 Sunil Chada.1 1 Introgen Therapeutics Inc., Houston, TX, United States; 2Surgical Oncology, UT-MD Anderson Cancer Center, Houston, TX, United States. 2 4
( ' 3 8:9999
*
0
"
; - ";/
' " ; "
' " ; 0
' " ;
" 7 ′ $*' -' / - 3 /
- 3 /
' " ; C G
"C ,
0 ' " ;
" C 3 ' 3
"
813. The Combination of Antisense K-ras RNA and Interferon-Alpha Induces Synergistic Cytotoxicity Against Pancreatic Cancer Cells Kazuteru Hatanaka, Koichi Suzuki, Shumpei Ohnami, Teruhiko Yoshida, Kazunori Aoki.
S265
) -#(# "
" @'D/
2",
" @'D -' @'D/ 23 .> ?
-' .> ?23/ ' @'D
3 @'D"
58H $&6# 6B;H 4,&8# ' @'D -899 #)/
# ( ( 3 3 23 ' .> ?23 4,&8# T4=;=# T4:;# T(A# 8T$&6# 23 3 @'D
"5 ": "=
' @'D ' .> ?23
# $&6# 58H ' @'D -899 #)/ :;5H ' .> ?23-899#)/ &8&H
# ( (
3 23 ' .> ?23 ' @'D @'D" / % 8 B DEEE'71,1F#
807. Induction of Apoptosis and Cell Cycle Stopped ransfer in Transfer with Adenovirus Mediated SART1 Gene T Human Lung and Breast T umor Cell Line Tumor Mami Hosokawa,1 Shigemitsu Takashima,1 Shigeaki Shichijo,2 Kyogo Itho,2 Hiro Wakasugi,3 Yoichi Takaue,3 Igor Dmitriev,4 David Curiel,4 Yuji Heike.5 1 Medical Oncology and Clinical Reserch, National Shikoku Cancer Center, Matsuyama, Ehime, Japan; 2Immunology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; 3 Pharmacology, National Cancer Center Reserch Institute, Tsukiji, Tokyo, Japan; 4Gene Therapy Program, University of Alabama at Birmingham, Alabama, Birmingham, United States. ('@ 8 1 3
G
CD'"',B
D C 3
('@ 8
('@ 8
%
3
('@ 8
" " -@ $/ C#)M89 3
'&65 #?;
,6 6:
:9H ;, 0 *"C6B9 N@;&"8
B9H ;,
N@;&"8 *"C6B9 $#(886
,%# ,6 ;, '&65 #?;
,%# ,6 ,%#
6: D '&65 #?;
- 8% , $,&2/ ,%# ('@ 8
' 8% , $,&2
,%#
S264
808. Enhancement of Thymidine Kinase-Mediated Killing of Malignant Glioma by BimS, a BH3-Only Cell Death Activator Takashi Yamaguchi,1 Takashi Okada,2 Mutsumi Nagai,1 Koichi Takeuchi,3 Souji Shinoda,1 Toshio Masuzawa,1 Keiya Ozawa,2 Toshiya Inaba.4 1 Department of Surgical Neurology, Jichi Medical School, Minami-kawachi, Tochigi, Japan; 2Division of Genetic Therapeutics, Jichi Medical School, Minami-kawachi, Tochigi, Japan; 3Department of Anatomy, Minami-kawachi, Tochigi, Japan; 4 Department of Molecular Oncology, Hiroshima University, Hiroshima, Hiroshima, Japan. C 3 -C(." / % - ./
C(." % . " @ 2", 2 2", "
3
C(." % . 0
3 % 2 2C=" 2",
$*' '
2>D 2D 2( 2(
D: 2>D 2D ( 2
C(." % .
C(." % . "
3 DN-'.," DN/ 2( -'.,"2(/ 2D -'.,"2D/ C(." -'.," / 0
,5= '.," 2( '.,"2D
" '.," ,5=
,6 2 ,5=2 3
2"3D '.,"2( '.,"2D
' 4,&8 '8;, "6=9 4=;= ,6
'.,"2( " " '.,"2( '.,"
4,&8 . '.,"2D '
'.,"2( '.," % .
69 2 '.,"2( '.," % .
' 3 2 23 - 2",
C(." % . / $
809. Adenoviral Delivery of Pro-Caspase3 to Ovarian Carcinoma Cells Induces Apoptosis and Enhances Sensitivity to Dominant-Negative Mutant Survivin Tristan R. McKay, Steven J. Bell, Tencho Tenev, Nicholas R. Lemoine, Iain A. McNeish. 1 ICRF Molecular Oncology Unit, Imperial College School of Medicine, London W12 0NN, United Kingdom. ( 3 0 " " 3 = 0
G
3 " =6' " = 0
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
!" " 5"
? " =6'
3 0 " =
810. Effects of HSV Amplicon V ectors Mediate TIMP-3 Vectors Gene T ransfer in Human Glioma Cell Lines Transfer Paula Y. P. Lam,1 ChuJun Yuan,1 Kam Man Hui.1 1 Cellular and Molecular Research, National Cancer Centre, Singapore.
891,= 1
! >*
# ! >*
0 ! >* " ! >*
! 'A
! >* 3 ' "! >*
>"
3
G
! >* ' "! >* " "
)
(
3 3 ->#/
># 1
3
G - 3 ##! / -
#!(/ #!"= ) 3 #!"=
I I I #E
C
3 C(."8
#!"= 3 3 ?
#!"=
#!"=
C #!"= $*'
@*'
C F -+ ( ,998 # =7 &58"B98/ $*' 1
1
88 3 89B % #!"= 8,389; % C F
3
&:H #) 89 0
#!"= 3
#!"= 3
$
"=B 4:;# 4,&8 (?;B; 85HI ,&HI &H
;, #)9& 3 "=B #) 9& &9
69H '
3
#)
812. Exploiting Molecular Pathways for Breast Cancer Treatment: Ad-mda7 Enhances Activity of Conventional Cancer Agents
81 1. 811.
!
C A" A" 0
A" @*'" 3
)
" -?*/
3
"
?*
?*" G ,V &V" -,"&'(/
Ad-PTEN: A Novel Anti-Melanoma Agent In V itro Vitro
Helena Yang,1 Abner Mhashilkar,1 Alexis Stewart,1 Su Ekmekcioglu,2 Yuji Saito,4 Kerry Seiger,1 Robert Schrock,1 Eric Onishi,1 Xin Swanson,1 Lou Zumstein,1 David Snary,3 Jack Roth,4 Rajagopal Ramesh,4 Elizabeth Grimm,2 Sunil Chada.1 1 Introgen Therapeutics Inc., Houston, TX, United States; 2 Bioimmunotherapy, UT, MD Anderson Cancer Center, Houston, TX, United States; 3Imperial Cancer Research Fund, London, United Kingdom; 4Thoracic and Cardiovascular Surgery, UT, MD Anderson Cancer Center, Houston, TX, United States. # G ! >* Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
Abner Mhashilkar,1 Kerry Seiger,1 Alexis Stewart,1 Kelly Hunt,2 Sunil Chada.1 1 Introgen Therapeutics Inc., Houston, TX, United States; 2Surgical Oncology, UT-MD Anderson Cancer Center, Houston, TX, United States. 2 4
( ' 3 8:9999
*
0
"
; - ";/
' " ; "
' " ; 0
' " ;
" 7 ′ $*' -' / - 3 /
- 3 /
' " ; C G
"C ,
0 ' " ;
" C 3 ' 3
"
813. The Combination of Antisense K-ras RNA and Interferon-Alpha Induces Synergistic Cytotoxicity Against Pancreatic Cancer Cells Kazuteru Hatanaka, Koichi Suzuki, Shumpei Ohnami, Teruhiko Yoshida, Kazunori Aoki.
S265